
_画板-1-1-300x300.png)
15 Years of Acne Patch Factory Manufacturing and Wholesale
You have your sample approved, packaging artwork finalized, and unit economics working at $14.99 retail. Then Amazon asks for your compliance documentation and the timeline that was supposed to be eight weeks becomes sixteen. Compliance does not wait for your launch date.
Buyers who treat compliance as an afterthought discover that MoCRA, FDA facility registration, and Amazon’s testing requirements can derail a launch. This article maps the compliance work that runs parallel to production, what documentation Amazon actually requests, and how to avoid the common delay points.
Standard hydrocolloid patches without drug claims are cosmetics in the US market. Under the Modernization of Cosmetics Regulation Act (MoCRA), both the manufacturing facility and the product must be registered with the FDA before entering US commerce.
Buyers assume compliance is the factory’s responsibility, place the order, and only think about FDA registration when Amazon requests it. By then, the factory may not be registered, the product not listed, and the listing gets suppressed. For a new brand, those weeks feel like years.
Compliance breaks into three parallel tracks. Trying to complete them sequentially is how buyers miss their launch window.
The factory must register under MoCRA. You cannot do this for them. You (the buyer) must list the product via the FDA Cosmetics Direct portal with the full ingredient list before marketing.
Amazon enforces via the Manage Your Compliance dashboard. Requests include COA, INCI list, Safety Data Sheets, GMP certs, and sometimes testing docs (stability, micro). Having docs ready prevents suppression.
Labels need INCI ingredients, net quantity, contact info, and country of origin. Avoid active claims (e.g., salicylic acid at 0.5-2%) unless you are prepared for OTC drug classification (Drug Facts label).
This shows what happens when compliance runs parallel vs. sequential to sample development.
| Phase | Sequential Approach (Late) | Parallel Approach (On Time) |
|---|---|---|
| Week 1-2 | Sample review and approval | Confirm factory FDA registration status |
| Week 3-4 | Begin compliance work | Submit ingredient list for FDA listing prep |
| Week 5-6 | Factory registration processing | Prepare labeling artwork for review |
| Week 7-8 | Product listing submission | Gather COA and GMP documentation |
| Week 9-12 | Amazon compliance response | Ready for Amazon listing submission |
| Week 13-16 | Resubmission, production delays | Production proceeds with compliance ready |
Before you approve the golden sample and place your production order, confirm these items with your factory:
Standard patches without drug claims are cosmetics. If they contain active levels of salicylic acid (0.5% – 2%) and make treatment claims, they cross into OTC drugs, requiring Drug Facts labeling and OTC monograph compliance.
Testing requests are risk-based. Common requests include stability testing, microbiological testing, and preservative efficacy testing. Being prepared reduces the risk of listing suppression.
The manufacturing facility is responsible. Private label buyers cannot register the factory; you can only confirm that they are registered before placing an order.
Your listing gets suppressed. You lose Buy Box eligibility and disappear from search results until you resubmit (usually a 90-day window). Have documents ready before launch.
_画板-1-e1760947912226.png)
Ningbo Alps Medical Technology Co., Ltd. 15 Years of Acne Patch Factory Manufacturing and Wholesale
©2026All Rights Reserved.
Xingwen Future Technology City, No. 1001 Tanjiang North Road, Shounan Subdistrict, Yinzhou District, Ningbo City
✔ Customize Formula, Shape, Color & Packaging
✔ Fast Lead Time, Direct Factory Price
✔ Professional Support Team, Quick Response